MORENO BRUNA, Beatriz

Dra.
Beatriz
MORENO
BRUNA
Facultat de Medicina i Ciències de la Salut
Departament de Ciències Bàsiques de Ciències de la Salut
Lectora
Extensió: 
5225
bmoreno@uic.es
Fotografia del professor

Formació Acadèmica de la Dra. MORENO BRUNA, Beatriz

  • Neurosciences
    Universidad de Navarra
  • Biology
    Universidad de Navarra (1997)

Publicacions de la Dra. MORENO BRUNA, Beatriz

Articles

  • Díaz, D.; Gutiérrez, M.; MORENO, B.; Martínez, J.; Pifarre, P.; García , A., 2018, "Mechanisms Involved in the Remyelinating Effect of Sildenafil", Journal of Neuroimmune Pharmacology, 13, 6-23.
  • MORENO, B.; Barroto, A.; Villoslada, P.; Alarcon, B.; Messeguer, A., 2016, "First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases", SCIENCE TRANSLATIONAL MEDICINE, 8, 184.
  • MORENO, B.; Agirrezabal, I.; Palacios, R.; Sepulcre, J.; Abernathy, A.; Saiz, A.; Llufriu, S.; Comabella, M.; Montalbán , X.; Martínez, A.; Arteta, D.; Villoslada, P., 2016, "Increased expression of dedicator-cytokinesis-10, caspase-2 and synaptotagmin-like 2 is associated with clinical disease activity in multiple sclerosis", Multiple Sclerosis and Demyelinating disorders.
  • MORENO, B.; Errea, O.; Gonzalez-Franquesa, A.; García-Roves , P.; Pablo, V., 2015, "The disruption of mitocondrial axonal transport is an early event in neuroinflammation", Journal of Neuroinflammation, 12.
  • Llufriu, S.; Sepulveda, M.; Blanco, Y.; Pedro, M.; MORENO, B.; Berenguer, J.; Gabilondo, I.; Martínez-Heras, E.; Sola-Valls, N.; Albert Arnaiz, J.; J. Andreu, E.; Fernández, B.; Bullich, S.; Sanchez-Dalmau , B.; Graus, F.; Villoslada, P.; Saiz, A., 2014, "Randomized Placebo-Controlled Phase II Trials of Autologous Mesenchymal Stem Cells in Multiple Sclerosis", PLoS One.
  • MORENO, B.; Llufiu, S.; Sepúlveda, M.; Blanco, Y.; Pedro, M.; Berenguer, J.; Gabilondo, I.; Martínez-Heras, E.; Sola-Valls, N.; Albert Arnaiz, J.; J. Andreu, E.; Fernández, B.; Bullich, S.; Sanchez-Dalmau , B.; Graus, F.; Villoslada, P.; Saiz, A., 2014, "Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis", PLoS One, 9.
  • MORENO, B.; Lopez, I.; Fernández, B.; Gottlieb, M.; Matute, C.; Sánchez-Gómez, M.; Domercq, M.; Giralt, A.; Alberch, J.; Zhang, H.; Parent, Jack M; Villoslada, P.; FRANCO, R., 2014, "Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine", PLoS One, 9.
  • Marro, M.; Taubes, A.; Abernathy, A.; Balint, S.; MORENO, B.; Sanchez-Dalmau , B.; Martinez-Lapiscina, E.; Amat-Roldan, I.; Petrov, D.; Villoslada, P., 2013, "Dynamic molecular monitoring of retina inflammation by in vivo Raman spectroscopy coupled with multivariate analysis", Journal of biophotonics.
  • MORENO, B.; Villoslada, P., 2013, "Neuroprotective Therapies for Multiple Sclerosis", European Neurological Review, 7.
  • Martínez-Pasamar, S.; Abad, E.; MORENO, B.; Vélez de Mednizabal, N.; Martinez-Forero, I.; García-Ojalvo, J.; Villoslada, P., 2013, "Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoinmmunity", BMC systems biology, 7.
  • di Penta, A.; MORENO, B.; Reix, S.; Fernández-Diez, B.; Villanueva, M.; Errea, O.; Escala, N.; Vandenbroek, K.; Comella, J.; Villoslada, P., 2013, "Oxidative Stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation", PLoS One, 8.
  • Mannara, F.; Valente, T.; Saura, J.; Graus, F.; Saiz, A.; MORENO, B., 2012, "Passive experimental autoinmune encephalomyelitis in C57BL/6 with MOG: evidence of involvement of B cells", PLoS One, 7.
  • MORENO, B.; Espejo, C.; Mestre, L.; Suardiaz, M.; Clemente, D.; de Castro, F.; Fernandez, O.; Montalban, X.; Villoslada, P.; Guaza, C., 2012, "Guías para el uso adecuado de modelos animales para el desarrollo de terapias en Esclerosis Múltiple", Revista de neurología (Internet), 54, 114.

Projectes de recerca de la Dra. MORENO BRUNA, Beatriz

  • Mecanismos celulares y moleculares del efecto neuroprotector del sildenafil en la encefalomielitis autoimmune experimental.
  • Mechanisms of axonal damage in neuroinflammation: new neuroprotection strategies.